| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2300-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8962
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9794
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-31 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9794
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8962
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 |
| filingDate |
2020-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2023-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2023-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102486043-B1 |
| titleOfInvention |
Composition for Preventing, Improving or Treating Inflammatory Diseases Comprising Brassica spp. or Allium spp.-Derived Extracellular Vesicles as Active Ingredients |
| abstract |
The present invention relates to a composition for the prevention, improvement or treatment of inflammatory diseases comprising brassica or allium plant-derived extracellular vesicles as an active ingredient. The extracellular vesicles derived from Brassica plants or Allium genus plants of the present invention have good intracellular penetration, and the delivered extracellular vesicles are interleukin-6 (IL-6), interleukin-1 beta (IL-1β) and COX-2 ( Since it has the effect of inhibiting the expression of cyclooxygenase-2), it can be usefully used for the treatment, improvement or prevention of inflammatory diseases. |
| priorityDate |
2020-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |